25.58
Adaptive Biotechnologies Corp (ADPT) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
0.96%
71.55
|
70.87 | 71.68 | 93.97 | 58.88 |
| Cost Of Revenue |
7.79%
20.16
|
18.71 | 18.22 | 18.16 | 18.00 |
| Research and Development |
18.92%
19.15
|
23.62 | - | - | - |
| Interest Income/Expense |
6.75%
2.694
|
2.889 | 2.954 | 2.971 | 2.948 |
| Costs And Expenses |
3.06%
87.32
|
90.08 | 84.45 | 83.68 | 83.92 |
| Operating Income/Loss |
17.89%
-15.77
|
-19.21 | -12.77 | 10.29 | -25.04 |
| Net Income/Loss |
99.56%
-39.94
|
-20.02 | -13.58 | 9.545 | -25.59 |
| Attributable To Noncontrolling Interest |
950.00%
-0.153
|
0.018 | - | -0.001 | 0.021 |
| Basic Average Shares |
2.79%
159.86
|
155.52 | 0.4735 | 152.43 | 152.08 |
| Diluted Average Shares |
2.79%
159.86
|
155.52 | 0.4735 | 163.16 | 152.08 |
| Basic Earnings Per Share |
92.31%
-0.25
|
-0.13 | -0.09 | 0.06 | -0.17 |
| Diluted Earnings Per Share |
92.31%
-0.25
|
-0.13 | -0.09 | 0.06 | -0.17 |
자본화:
|
볼륨(24시간):